COMET study European Study: carvedilol vs metoprolol

被引：0
|
作者：
Perrone, Sergio V. [1 ]
Diez, Fabian [2 ]
Allal, Oscar
Allende, Guillermo
Amuchastegui, Marcos
Colque, Roberto
Poy, Carlos
D'Ortencio, Alfredo
Sarjanovich, Rodolfo
Tacchi, Hector
Zelaya, Felix
机构：
[1] Inst FLENI, Jefe Div Trasplante Cardiaco, Buenos Aires, DF, Argentina
[2] Hosp Italiano Garibaldi, Serv Cardiol, Med Cardiol Jefe Unidad Coronaria, Rosario, Santa Fe, Argentina
来源：
INSUFICIENCIA CARDIACA | 2006年 / 1卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 189
页数：7
相关论文
共 50 条
  • [1] Commentary on the carvedilol or Metoprolol European Trial (COMET)
    Poole-Wilson, PA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (9A): : 40B - 42B
  • [2] Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
    Poole-Wilson, PA
    Swedberg, K
    Cleland, JGF
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lubsen, J
    Lutiger, E
    Metra, M
    Remme, WJ
    Torp-Pedersen, C
    Scherhag, A
    Skene, A
    [J]. LANCET, 2003, 362 (9377): : 7 - 13
  • [3] A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET)
    Cleland, JGF
    Goode, K
    Erhardt, L
    Remme, WJ
    Charlesworth, A
    Poole-Wilson, PA
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Metra, M
    Swedberg, K
    Trop-Pedersen, C
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (02) : 139 - 152
  • [4] Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET
    Poole-Wilson, PA
    Cleland, JGF
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Metra, M
    Remme, WJ
    Swedberg, K
    Torp-Pedersen, C
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) : 321 - 329
  • [5] A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET)
    John G.F. Cleland
    Kevin Goode
    Leif Erhardt
    Willem J. Remme
    Andrew Charlesworth
    Philip A. Poole-Wilson
    Andrea Di Lenarda
    Peter Hanrath
    Michel Komajda
    Marco Metra
    Karl Swedberg
    Christian Torp-Pedersen
    [J]. Cardiovascular Drugs and Therapy, 2004, 18 : 139 - 152
  • [6] Lack of heart rate effects on the mortality benefits of carvedilol compared to metoprolol in the patients with heart failure: Results from the Carvedilol or Metoprolol European Trial (COMET)
    Metra, M
    Cleland, JG
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lutiger, B
    Poole-Wilson, PA
    Remme, WJ
    Scherhag, A
    Charlesworth, A
    Swedberg, K
    Torp-Pedersen, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 157A - 157A
  • [7] Metoprolol vs carvedilol in heart failure
    Michael Norton
    [J]. Current Controlled Trials in Cardiovascular Medicine, 2000, 2 (1):
  • [8] Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
    Torp-Pedersen, Christian
    Metra, Marco
    Charlesworth, Andrew
    Spark, Phillip
    Lukas, Mary Ann
    Poole-Wilson, Philip A.
    Swedberg, Karl
    Cleland, John G. F.
    Di Lenarda, Andrea
    Remme, Willem J.
    Scherhag, Armin
    [J]. HEART, 2007, 93 (08) : 968 - 973
  • [9] A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure - A report from the Carvedilol or Metoprolol European Trial (COMET)
    Cleland, JGF
    Charlesworth, A
    Lubsen, J
    Swedberg, K
    Remme, WJ
    Erhardt, L
    Di Lenarda, A
    Komajda, M
    Metra, M
    Torp-Pedersen, C
    Poole-Wilson, PA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1603 - 1611
  • [10] Beta-blocker dose does not influence the beneficial effects of carvedilol compared to metoprolol in the patients with heart failure: Results from the Carvedilol or Metoprolol European Trial (COMET)
    Metra, M
    Poole-Wilson, PA
    Cleland, JG
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lubsen, J
    Lutiger, B
    Remme, WJ
    Scherhag, A
    Charlesworth, A
    Torp-Pedersen, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 206A - 206A
12345